OncoEthix Company

Oncoethix is a Swiss company founded in 2007 by former associates at Cvitkovic & Associes Consultants SA. The company's goal is to develop 3 to 5 new drugs for cancer treatment and seek pharmaceutical partners for funding and commercialization. The founders have a successful track record in bringing oncology leads to global markets. Oncoethix has in-licensed three promising cancer drug candidates, with two currently in clinical development. The company was initially financed by the founders and received a Series A financing of 3.7 million Swiss francs in 2009 from venture capital firms Index Ventures and Endeavour Vision.

Investor Type: Company
Investors Number: 5
Industry: PharmTech
Number Of Exists: Series B
Funding Status: M&A
Technology: Anti-infective Drugs
Employee Number: 51-100
Headquarters: Lausanne, Vaud
Last Funding Type: Series B
Total Funding: CHF22.2M
Investment Stage: N/A
Founded Date: 2007